window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : October 19, 2025

  • News
  • About Us
Contact Us

Machine Learning

  • Artificial Intelligence,Biomanufacturing,Digital Health,Drug Development,Technology and platforms

    The path to the autonomous lab: balancing innovation, culture, and compliance

    Laboratories across the pharmaceutical industry are moving closer to full [...]

    October 16, 2025
  • Artificial Intelligence,Clinical Development,Digital Health,Drug Development

    New AI tool offers real-time insights into clinical trial participant behavior

    Cognivia has launched Cognivia Signal, an AI-powered platform designed to [...]

    October 12, 2025
  • Artificial Intelligence,Biologics & Biosimilars,Drug Development,Precision medicine,Research & Development

    Latent Labs unveils AI model Latent-X for instant, lab-validated protein binder design

    No-code platform opens early access to generative binder design with [...]

    August 1, 2025
  • Clinical Development,Clinical Trials,Patient Centricity,Technology and platforms

    Linus Health to showcase AI tools for brain health detection and trial recruitment at AAIC 2025

    Linus Health will present new findings on its AI-driven cognitive [...]

    July 23, 2025
  • Artificial Intelligence,Biologics & Biosimilars,Cell & Gene Therapy,Clinical Development

    Shift Bioscience tackles AI model flaws to advance rejuvenation discovery

    New study proposes AI-driven framework to refine gene target discovery [...]

    July 4, 2025
  • Artificial Intelligence,Drug Development,Technology and platforms

    Optibrium and TalTech launch EU-funded PhD to advance sustainable drug discovery

    Partnership aims to boost predictive metabolism models using machine learning [...]

    July 2, 2025
  • Artificial Intelligence,CDMOs & Manufacturing,Drug Development,Technology and platforms

    AI can’t thrive in chaos: New survey finds labs still struggling with basics

    A new industry survey has revealed that while life sciences [...]

    June 27, 2025
  • Artificial Intelligence,Biologics & Biosimilars,Drug Development,Rare Diseases

    Game-changing £7.5M prize launches to unlock AI drug targets for ALS

    20 global teams will receive early-stage funding and access to [...]

    June 25, 2025
  • Oncology,Technology and platforms

    Mainz Biomed launches feasibility study to assess pancreatic cancer biomarker panel

    Mainz Biomed has initiated a feasibility study as part of [...]

    June 11, 2025
  • Artificial Intelligence,Clinical Trials,Drug Development,Technology and platforms

    PhaseV and Crohn’s & Colitis Foundation join forces to fast-track IBD clinical trials with AI

    A new collaboration aims to tackle the toughest challenges in [...]

    May 28, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • MaxCyte signs platform licence with Moonlight Bio to advance T cell therapies for solid tumours
    Categories: Biotech, Cell & Gene Therapy, Partnerships & Funding, Research & Development
  • Nordic Life Science Days 2025 opens in Gothenburg with calls for deeper collaboration and global investment
    Categories: European biotech, Events and Conferences, Global health, Healthcare leadership, Market Access & Commercialization, Partnerships & Funding, Research & Development
  • New AI tool offers real-time insights into clinical trial participant behavior
    Categories: Artificial Intelligence, Clinical Development, Digital Health, Drug Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top